SIGN UP

Ricky Sun, Bain Capital Life Sciences partner

February 7, 2025 11:06 AM ESTUpdated 11:59 AM

Bain buys Mitsubishi Tanabe Pharma in $3.3B bet on Japan

Ayisha Sharma

News Reporter

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

view job offer post your job now

TRENDING NOW

Takeda announces handful of pipeline cuts in effort to ‘pivot resources’

GSK awaits Nucala decision after FDA target date passes

AI-focused biotech insitro cuts 22% of staff, citing 'tumultuous market'

'Find a way, or make one': How two scientists hope to revitalize CRISPR's rare disease crisis

AstraZeneca loses appeals court fight over IRA drug price negotiations

sponsored

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges